Keywords: Merck KGaA, Sanofi-Aventis, Sanofi Pasteur, Genzyme

Merck KGaA replaces Schnee; Sanofi-Aventis makes senior executive change and extends Genzyme tender offer

Article | 13 December 2010

Print This

Following rumor and speculation over the weekend, this morning German drug major Merck KGaA (MRK: DE) announced that Stefan Oschmann ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in